🇺🇸 FDA
Pipeline program

Sodium valproate

CRE-2004.399

Approved small_molecule active

Quick answer

Sodium valproate for Epilepsy is a Approved program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Chinese University of Hong Kong
Indication
Epilepsy
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials